← Open Payments lookup

MARCIO JABLONKA: Open Payments

NPI 1619130820 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$604 in 28 payments from 11 companies in 2025. Trend: 2023 $330 · 2024 $600 · 2025 $604

Food & beverage: $604
CompanyPaymentsAmount
ABBVIE INC.15$298
AstraZeneca Pharmaceuticals LP2$54
GlaxoSmithKline, LLC.2$51
Exact Sciences Corporation2$38
PFIZER INC.1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
Baxter Healthcare1$25
E.R. Squibb & Sons, L.L.C.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$21
Lilly USA, LLC1$14

Products named: UBRELVY, QULIPTA, ELIQUIS, AIRSUPRA, VRAYLAR, Cologuard Collection Kit, CAPLYTA, SHINGRIX.

Industry payments across NH — which companies pay providers there.